Nawroth R, Weckermann D, Retz M
Klinik und Poliklinik für Urologie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Straße 22, 81675, München, Deutschland,
Urologe A. 2014 Apr;53(4):514-8. doi: 10.1007/s00120-014-3445-0.
The prognosis of prostate and bladder cancer patients is predominantly determined by the detection of distant sites of metastasis. In clinical routine, virtually only lymph node staging is of relevance to determine metastasis. Detection and characterization of disseminated tumor cells in peripheral blood or bone marrow is an additional parameter of prognostic significance. In this article, we will summarize recent progress on the prognostic value of disseminated tumor cells in bone marrow and its translation into routine clinical analysis.
前列腺癌和膀胱癌患者的预后主要取决于远处转移部位的检测。在临床实践中，实际上只有淋巴结分期与确定转移有关。外周血或骨髓中播散肿瘤细胞的检测和特征分析是另一个具有预后意义的参数。在本文中，我们将总结骨髓中播散肿瘤细胞预后价值的最新进展及其在常规临床分析中的应用。
